Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea · Delayed Price · Currency is KRW 5,410.00
+20.00 (0.37%)
Sep 11, 2026, 3:30 PM KST
Kyongbo Pharmaceutical Market Cap
Kyongbo Pharmaceutical has a market cap or net worth of 129.34 billion as of September 11, 2026. Its market cap has increased by 1.69% in one year.
Market Cap
129.34B
Enterprise Value
273.51B
Revenue
279.55B
Ranking
n/a
PE Ratio
25.64
Stock Price
5,410.00
ChartMarket Cap Chart
Since June 29, 2015, Kyongbo Pharmaceutical's market cap has decreased from 818.81B to 129.34B, a decrease of -84.20%. That is a compound annual growth rate of -15.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 129.34B | -6.24% |
| Dec 30, 2025 | 137.94B | -7.23% |
| Dec 30, 2024 | 148.70B | -25.86% |
| Dec 28, 2023 | 200.58B | -16.10% |
| Dec 29, 2022 | 239.07B | -6.98% |
| Dec 30, 2021 | 257.00B | -34.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Daihan Pharmaceutical | 157.88B |
| Jeil Pharmaceutical Co.,Ltd | 150.67B |
| Hana Pharm | 150.36B |
| Samil Pharmaceutical Co.,Ltd | 149.38B |
| Ilyang Pharmaceutical Co.,Ltd | 148.06B |
| Ilsung Is | 145.30B |
| Dongwha Pharm.Co.,Ltd | 144.13B |
| Dong Sung Bio Pharm.Co.,Ltd. | 137.45B |